Phoenix Group PLC Posts Stellar 2024 First Quarter Results with Surge in Assets and Profits
May 17, 2024 08:00 ET | Phoenix Group PLC
Dubai, UAE, May 17, 2024 (GLOBE NEWSWIRE) -- Phoenix Group PLC (ADX:PHX), the leading provider of web3, crypto, and blockchain technologies in the region, has announced impressive financial results...
Yahoo Logo 1029x579.jpg
BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week
May 16, 2024 16:55 ET | BIO-key International, Inc.
BIO-key Expects to File Audited 2023 Results on Form 10-K & Report Q1’24 Results with an Investor Call Next Week.
SYENSQO - Resultaten
SYENSQO - Resultaten Eerste Kwartaal 2024
May 16, 2024 00:45 ET | Syensqo SA
SYENSQO EERSTE KWARTAAL 2024 RESULTATEN Brussel, 16 mei 2024, 6.45 uur CEST VERBETERD JAAR-OP-JAAR VOLUMEMOMENTUM IN Kw1 2024ONDERLIGGENDE EBITDA VAN €363 MILJOEN MET STERKE OPEENVOLGENDE...
SYENSQO - Résultats
SYENSQO - Résultats du Premier Trimestre 2024
May 16, 2024 00:45 ET | Syensqo SA
RÉSULTATS DU T1 2024 DE SYENSQO Bruxelles, 16 mai 2024, 6h45 CEST AMÉLIORATION DES VOLUMES EN GLISSEMENT ANNUEL AU PREMIER TRIMESTRE 2024EBITDA SOUS-JACENT DE €363 MILLIONS, FORTE PROGRESSION...
SYENSQO - First Quar
SYENSQO - First Quarter 2024 Results
May 16, 2024 00:45 ET | Syensqo SA
SYENSQO FIRST QUARTER 2024 RESULTS Brussels, May 16, 2024, 6:45 a.m. CEST IMPROVED YEAR-ON-YEAR VOLUME MOMENTUM IN Q1 2024UNDERLYING EBITDA OF €363 MILLION WITH STRONG SEQUENTIAL...
Cavco_Logo.png
Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2024 Fourth Quarter and Year End Earnings Release and Conference Call Webcast
May 15, 2024 20:50 ET | Cavco Industries, Inc.
PHOENIX, May 15, 2024 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended March 30, 2024 on Thursday, May 23, 2024 after the...
Vaccinex logo
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 18:00 ET | Vaccinex, Inc.
Last patient last visit in SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease in early June 2024. $8.2 million of new financing in Q1.
CLC Logo.png
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
May 15, 2024 17:00 ET | Christina Lake Cannabis Corp.
VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for...
AON_Logo_Vert_Color.png
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results
May 15, 2024 16:47 ET | American Oncology Network
First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth of 7.1% as compared to the prior year quarter Added 17 new...
Battalion Logo Pantone.png
Battalion Oil Corporation Announces First Quarter 2024 Financial and Operating Results
May 15, 2024 16:32 ET | Battalion Oil Corporation
HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the first quarter of 2024....